Factors Associated with Echocardiographic Abnormalities in Patients with Chronic Kidney Disease in a Tertiary Hospital in Ivory Coast
- 1 Department of Internal Medicine, University Teaching Hospital (CHU) of Bouaké, Bouaké, Côte d'Ivoire
- 2 Nephrology-Hemodialysis Department, University Teaching Hospital (CHU) of Yopougon, Abidjan, Côte d'Ivoire
- 3 Department of Internal Medicine, University Teaching Hospital (CHU) of Bouaké, Bouaké, Côte d'Ivoire
- 4 Department of Internal Medicine, University Teaching Hospital (CHU) of Bouaké, Bouaké, Côte d'Ivoire
- 5 Department of Internal Medicine, University Teaching Hospital (CHU) of Bouaké, Bouaké, Côte d'Ivoire
- 6 Department of Internal Medicine, University Teaching Hospital (CHU) of Bouaké, Bouaké, Côte d'Ivoire
- 7 Nephrology-Hemodialysis Department, University Teaching Hospital (CHU) of Yopougon, Abidjan, Côte d'Ivoire
Abstract
Background: Cardiovascular risk factors (CVRF) are very frequent in pa-tients with chronic kidney disease (CKD) and impose a new environment to which the heart must adapt. Cardiac ultrasound is a non-invasive and easy-to-perform examination that allows quantitative and qualitative assessment of the anatomy and function of the heart. The objectives of this study were to describe abnormalities observed on trans-thoracic Doppler-echocar-diography and to investigate the factors associated with them. Materials and Method: This was a monocentric retrospective cross-sectional study conducted in CKD patients hospitalized in a hospital center in Côte d'Ivoire from January 2017 to December 2018. Results: One hundred and four cases were collected with a mean age of 48.87 ± 14.47 years and a sex ratio of 1.7. Patients with end-stage-renal-disease (ESRD) represented 83.7% with 55.8% of cases of chronic glomerulonephritis. Cardiovascular risk factors were 100% anemia, 84.6% inflammatory profile, 77.9% hypertension, 76.9% hypocalcemia and in 67.3% oedema. Cardiac abnormalities were observed in 78.8% of patients. Left ventricular hypertrophy (LVH), accounting for 20.2% of cases, was associated with male gender (OR 0.127 CI 0.025 - 0.643; p = 0.013) and hypertensive nephropathy (OR 0.189 CI 0.056 - 0.637; p = 0.007). History of hypertension (OR 0.297 CI 0.084 - 1.050; p = 0.060) and diabetes (OR 5.315 CI 1.260 - 22.419; p = 0.023), hypertensive nephropathy (OR 0.174 CI 0.052 - 0.585; p = 0.005) and hypocalcemia (OR 6.094 CI 1.723 - 21.559; p = 0.005) are incriminated in the development of left ventricular dilatation (LVD) which accounted for 38.5% of cases. Conclusion: Left ventricular hypertrophy and dilatation are the main echocardiographic abnormalities observed in our population.
- Foley, R.N. and Collins, A.J. (2007) End-Stage Renal Disease in the United States: An Update from the United States Renal Data System. Journal of the American Society of Nephrology, 18, 2644-2648. https://doi.org/10.1681/ASN.2007020220
- Manjunath, G., Tighiouart, H., Coresh, J., et al. (2003) Level of Kidney Function as a Risk Factor for Cardiovascular Outcomes in the Elderly. Kidney International, 63, 1121-1129. https://doi.org/10.1046/j.1523-1755.2003.00838.x
- Lullo, L.D., Gorini, A., Russo, D., Santoboni, A. and Ronco, C. (2015) Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Medicine, 5, 254-266. https://doi.org/10.1159/000435838
- Wheeler, D.C. (2002) Cardiomyopathie urémique. Flammarion Médecine-Sciences, Actualités Néphrologiques.
- Herzog, C.A., Asinger, R.W., Berger, A.K., et al. (2011) Cardiovascular Disease in Chronic Kidney Disease. A Clinical Update from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney International, 80, 572-586. https://doi.org/10.1038/ki.2011.223
- Sumaili, E.K., Krzesinski, J.M., Zinga, C.V., Cohen, E.P., Delanaye, P., et al. (2009) Prevalence of Chronic Kidney Disease in Kinshasa: Results of a Pilot Study from the Democratic Republic of Congo. Nephrology Dialysis Transplantation, 24, 117-122. https://doi.org/10.1093/ndt/gfn469
- Panjiyar, R., Sharma, R., Laudari, S., Gutpa, M., Ghimire, M., Subedi, P. and Ubramanyam, G. (2017) Cardiovascular Complications in End Stage Renal Disease in a Tertiary Hospital in Nepal. Journal of College of Medical Sciences-Nepal, 13, 279-283.
- Yaw, A.A., Laryea, D.O., Bedu-Addo, G., Nkum, B.C. and Plange-Rhule, J. (2017) Left Ventricular Hypertrophy among Chronic Kidney Disease Patients in Ghana. The Pan African Medical Journal, 28, 79-88.
- Keates, A.K., Mocumbi, A.O., Ntsekhe, M., Sliwa, K. and Stewart, S. (2017) Cardiovascular Disease in Africa: Epidemiological Profile and Challenges. Nature Reviews Cardiology, 14, 273-293.
- Babua, C., Kalyesubula, R., Okello, E., Kakande, B., Sebatta, E., Mungoma, M. and Mondo, C. (2015) Pattern and Presentation of Cardiac Diseases among Patients with Chronic Kidney Disease Attending a National Referral Hospital in Uganda: A Cross Sectional Study. BMC Nephrology, 16, Article No. 126. https://doi.org/10.1186/s12882-015-0128-z
- Mailloux, L.U. and Levey, A.S. (1998) Hypertension in Patients with Chronic Renal Disease. American Journal of Kidney Diseases, 32, S120-S141. https://doi.org/10.1053/ajkd.1998.v32.pm9820471